Literature DB >> 2218819

Selection of therapy for stage III breast cancer.

S M Swain1.   

Abstract

Locally advanced breast cancer is a heterogenous group including both operable and inoperable lesions. Local surgery or radiation alone produces poor survival rates, indicating micrometastases at diagnosis. Systemic chemotherapy as part of multimodality regimens has increased the length and rate of disease-free survival.

Entities:  

Mesh:

Year:  1990        PMID: 2218819     DOI: 10.1016/s0039-6109(16)45230-8

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  Prognostic factors affecting locoregional recurrence in patients with stage IIIB noninflammatory breast cancer.

Authors:  Kaptan Gülben; Uğur Berberoğlu; Aziz Cengiz; Hüseyin Altınyollar
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

Review 2.  Systemic therapy in breast cancer: efficacy and cost utility.

Authors:  J F Corry; P E Lønning
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

3.  Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors.

Authors:  Daejin Kim; Talia Hoory; Archana Monie; Annie Wu; Wei-Ting Hsueh; Sara I Pai; Chien-Fu Hung
Journal:  J Biomed Sci       Date:  2010-07-26       Impact factor: 8.410

4.  Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer.

Authors:  D K Armstrong; J H Fetting; N E Davidson; G B Gordon; A M Huelskamp; M D Abeloff
Journal:  Breast Cancer Res Treat       Date:  1993-12       Impact factor: 4.872

5.  Combination of viral oncolysis and tumor-specific immunity to control established tumors.

Authors:  Chi-Mu Chuang; Archana Monie; Annie Wu; Sara I Pai; Chien-Fu Hung
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531

6.  Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide.

Authors:  Tae Heung Kang; Jayne Knoff; Benjamin Yang; Ya-Chea Tsai; Liangmei He; Chien-Fu Hung; T-C Wu
Journal:  Cell Biosci       Date:  2013-12-20       Impact factor: 7.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.